Global Hemostasis Diagnostics Market Size, Share, Forecast Report, 2020-2027

The global Hemostasis Diagnostics market garnered revenue around USD 2.9 Billion in 2019 and projected to reach USD 4.8 Billion in 2027, with at a compound annual growth rate (CAGR) 8.9% throughout the estimate period from 2020 to 2027.

Malfunction of the body’s ability to clot blood is known as coagulation disorders. These disorders can either lead to hemorrhage or thrombosis. There are various reasons that can cause coagulation disorders. These disorders can be either acquired or hereditary. Some of the major causes of coagulation disorders which can result in bleeding are hemophilia, von Willebrand disease, and platelet dysfunction. Other causes of coagulation disorders which can lead to bleeding are vitamin K deficiency, disseminated intravascular coagulation, and other clotting factor deficiencies

According to National Hemophilia Foundation, Hemophilia A is about four times as common as hemophilia B.  The number of people with hemophilia in the United States is estimated to be about 20,000 individuals. Asia Pacific is likely to be a highly lucrative market for hemostasis diagnostics and it is expected to expand at a high CAGR during the forecast period. High per capita income has increased the consumption of diagnostic and therapy products in the region. The rapid expansion of the market in the region can be attributed to the numerous government initiatives undertaken to improve the health care infrastructure. The market in the region is estimated to expand rapidly as compared to other regions due to shift in base of pharmaceutical companies and clinical research industries from developed regions to developing regions such as China and India

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded,COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Hemostasis Diagnostics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Hemostasis Diagnostics market growth.

The global Hemostasis Diagnostics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

Key players in the global market include Abbott Laboratories, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Siemens Healthineers, Instrumentation Laboratory, Danaher Corporation (Beckman Coulter), and Grifols, S.A.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Hemostasis Diagnostics Market, by Product

• Laboratory Systems
  • Automated Systems
  • Semi-automated Systems
  • Manual Systems
• Consumables
• Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market, By Test Type

• Prothrombin Test Time (PT)
• Activated partial thromboplastin time (APTT)
• Fibrinogen degradation products (FDP)
• Activated Clotting Time
• Platelet Aggregation Test
• D Dimer
• Others

Global Hemostasis Diagnostics Market, by End-user

• Hospital/Clinics
• Independent Diagnostic Laboratories
• Home Care Settings
• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA